Answers are grounded in this paper and cite their sources.
A patient with severe Guillain-Barré syndrome responded to treatment with high-dose intravenous immunoglobulins. It is suggested, on the basis of recent case reports, that immunoglobulins may have an important rôle in the future treatment of this immune-mediated disease.
No takes yet. Share an insight, caveat, or question.
A. RAHAG (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: